​
​

Soleno Therapeutics (SLNO) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Soleno Therapeutics Revenue Highlights

00

Soleno Therapeutics Revenue by Period

Soleno Therapeutics Revenue by Year

DateRevenueChange
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31--100.00%
2017-12-31$-1.55B-107145.41%
2016-12-31$1.45M274.34%
2015-12-31$387.56K100.00%
2014-12-31--100.00%
2013-12-31$3.00M100.00%
2012-12-31--

Soleno Therapeutics generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Soleno Therapeutics Revenue by Quarter

DateRevenueChange
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$3.45M100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31--100.00%
2017-12-31$734.95M100.00%
2017-09-30--100.00%
2017-06-30$1.00K-99.62%
2017-03-31$265.00K-6.62%
2016-12-31$283.79K-13.74%
2016-09-30$329.00K-15.86%
2016-06-30$391.00K-12.53%
2016-03-31$447.00K85.05%
2015-12-31$241.56K162.56%
2015-09-30$92.00K187.50%
2015-06-30$32.00K45.45%
2015-03-31$22.00K100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30--100.00%
2013-03-31$3.00M-

Soleno Therapeutics generated - in revenue during Q2 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Soleno Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ONTXTraws Pharma$226.00B$56.00K
VECTVectivBio$27.34M$676.00K
CAPRCapricor Therapeutics$25.18M$2.26B
BOLTBolt Biotherapeutics$7.88M$1.14M
PULMPulmatrix$7.30M$366.00K
LYRALyra Therapeutics$1.56M$195.00K
CBIOGyre Therapeutics$794.00K-
XFORX4 Pharmaceuticals-$560.00K
SLNOSoleno Therapeutics--
BPTHBio-Path--
DAWNDay One Biopharmaceuticals-$20.07M
MBRXMoleculin Biotech--
ABOSAcumen Pharmaceuticals--
INZYInozyme Pharma--
BNTCBenitec Biopharma--
ALRNAileron Therapeutics--
AKTXAkari Therapeutics--
ANNXAnnexon--
DFFNCervoMed--

SLNO Revenue FAQ

What is Soleno Therapeutics’s yearly revenue?

Soleno Therapeutics's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. SLNO's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

What is Soleno Therapeutics’s quarterly revenue?

Soleno Therapeutics's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). SLNO's quarterly revenue for Q4 2023 was $3.45M, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).

What is Soleno Therapeutics’s revenue growth rate?

Soleno Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.